REQUEST A DEMO
Total
USD $0.00
Search more companies

Nyrvusano Pharmaceuticals SRL (Romania)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Nyrvusano Pharmaceuticals SRL Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Nyrvusano Pharmaceuticals SRL is an enterprise based in Romania. Its main office is in Bucharest. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was established on September 12, 2017. 20 (2025) employees currently work for Nyrvusano Pharmaceuticals SRL. In 2024, the company reported a net sales revenue increase of 48.3%. Its’ total assets recorded a growth of 55.27%. The net profit margin of Nyrvusano Pharmaceuticals SRL increased by 0.22% in 2024.

Headquarters
Strada Petru Si Pavel Nr. 61b
Bucharest; Bucharest;

Contact Details: Purchase the Nyrvusano Pharmaceuticals SRL report to view the information.

Basic Information
Total Employees:
Purchase the Nyrvusano Pharmaceuticals SRL report to view the information.
Registered Capital:
Purchase the Nyrvusano Pharmaceuticals SRL report to view the information.
Financial Auditors:
Purchase the Nyrvusano Pharmaceuticals SRL report to view the information.
Incorporation Date:
September 12, 2017
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Nyrvusano Pharmaceuticals SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
48.3%
Total Operating Revenue
49.23%
Operating Profit
60.38%
EBITDA
58.71%
Net Profit/Loss for the Period
49.17%
Total Assets
55.27%
Total Equity
45.45%
Operating Profit Margin
3.39%
Net Profit Margin
0.22%
Return on Equity (ROE)
1.38%
Quick Ratio
-5.05%
Cash Ratio
-2.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?